Literature DB >> 29399195

Piperlongumine inhibits cancer stem cell properties and regulates multiple malignant phenotypes in oral cancer.

Yin-Ju Chen1,2,3,4,5, Chia-Chun Kuo1, Lai-Lei Ting1, Long-Sheng Lu1,2,3, Ya-Ching Lu6, Ann-Joy Cheng6, Yun-Tien Lin7, Chien-Ho Chen7, Jo-Ting Tsai8,9, Jeng-Fong Chiou1,8,10.   

Abstract

Piperlongumine (PL), a natural product of Piper longum, inhibits multiple malignant phenotypes. Therefore, the present study examined whether PL suppresses cancer stemness in oral cancer. The cellular effects of PL were determined by examining alterations in tumor sphere formation, cell migration, invasion, proliferation ability, chemosensitivity and radiosensitivity. Reverse transcription-quantitative polymerase chain reaction analysis and western blotting were performed in order to determine molecular expression levels. The present study revealed that PL inhibited cancer stem cell-forming ability and suppressed the expression of the stemness-related transcription factors SRY-Box 2, POU class 5 homeobox 1, and Nanog homeobox. However, it increased the expression of the differentiation marker cytokeratin 18. PL also suppressed cell migration and invasion, resulting in the elimination of the epithelial-mesenchymal transition. Furthermore, PL increased chemo- and radiosensitivity and suppressed tumor growth in vitro and in vivo. The results of the present study suggested that PL inhibits malignant phenotypes via the suppression of cancer stemness in oral cancer. Thus, PL may serve as an effective therapeutic agent for oral cancer.

Entities:  

Keywords:  cancer stem cells; chemosensitivity; epithelial-mesenchymal transition; oral cancer; piperlongumine; radiosensitivity

Year:  2017        PMID: 29399195      PMCID: PMC5774503          DOI: 10.3892/ol.2017.7486

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  53 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Core transcriptional regulatory circuitry in human embryonic stem cells.

Authors:  Laurie A Boyer; Tong Ihn Lee; Megan F Cole; Sarah E Johnstone; Stuart S Levine; Jacob P Zucker; Matthew G Guenther; Roshan M Kumar; Heather L Murray; Richard G Jenner; David K Gifford; Douglas A Melton; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

3.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Authors:  Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl
Journal:  Cancer Res       Date:  2006-09-21       Impact factor: 12.701

Review 4.  Global epidemiology of oral and oropharyngeal cancer.

Authors:  Saman Warnakulasuriya
Journal:  Oral Oncol       Date:  2008-09-18       Impact factor: 5.337

Review 5.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 6.  Overview of the therapeutic potential of piplartine (piperlongumine).

Authors:  Daniel P Bezerra; Claudia Pessoa; Manoel O de Moraes; Nicolau Saker-Neto; Edilberto R Silveira; Leticia V Costa-Lotufo
Journal:  Eur J Pharm Sci       Date:  2012-12-11       Impact factor: 4.384

7.  Analysis of risk factors of predictive local tumor control in oral cavity cancer.

Authors:  Chun-Ta Liao; Joseph Tung-Chieh Chang; Hung-Ming Wang; Shu-Hang Ng; Chuen Hsueh; Li-Yu Lee; Chih-Hung Lin; I-How Chen; Shiang-Fu Huang; Ann-Joy Cheng; Tzu-Chen Yen
Journal:  Ann Surg Oncol       Date:  2007-12-29       Impact factor: 5.344

8.  Snail-induced epithelial-mesenchymal transition promotes cancer stem cell-like phenotype in head and neck cancer cells.

Authors:  Takashi Masui; Ichiro Ota; Jong-In Yook; Shinji Mikami; Katsunari Yane; Toshiaki Yamanaka; Hiroshi Hosoi
Journal:  Int J Oncol       Date:  2013-12-23       Impact factor: 5.650

Review 9.  NF-κB, stem cells and breast cancer: the links get stronger.

Authors:  Kateryna Shostak; Alain Chariot
Journal:  Breast Cancer Res       Date:  2011-07-26       Impact factor: 6.466

10.  DSG3 facilitates cancer cell growth and invasion through the DSG3-plakoglobin-TCF/LEF-Myc/cyclin D1/MMP signaling pathway.

Authors:  Yin-Ju Chen; Li-Yu Lee; Yin-Ka Chao; Joseph T Chang; Ya-Ching Lu; Hsiao-Fang Li; Ching-Chi Chiu; Yi-Chen Li; Yan-Liang Li; Jeng-Fong Chiou; Ann-Joy Cheng
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

View more
  4 in total

1.  The effect of piperlongumine on endothelial and lung adenocarcinoma cells with regulated expression of profilin-1.

Authors:  Maciej Gagat; Marta Hałas-Wiśniewska; Wioletta Zielińska; Magdalena Izdebska; Dariusz Grzanka; Alina Grzanka
Journal:  Onco Targets Ther       Date:  2018-11-22       Impact factor: 4.147

2.  Piperlongumine inhibits the growth of non-small cell lung cancer cells via the miR-34b-3p/TGFBR1 pathway.

Authors:  Xinhua Lu; Chenyang Xu; Zhexuan Xu; Chunya Lu; Rui Yang; Furui Zhang; Guojun Zhang
Journal:  BMC Complement Med Ther       Date:  2021-01-07

Review 3.  Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells.

Authors:  Valdenizia R Silva; Luciano de S Santos; Rosane B Dias; Claudio A Quadros; Daniel P Bezerra
Journal:  Cancer Commun (Lond)       Date:  2021-11-17

Review 4.  The promising potential of piperlongumine as an emerging therapeutics for cancer.

Authors:  Dey Parama; Varsha Rana; Sosmitha Girisa; Elika Verma; Uzini Devi Daimary; Krishan Kumar Thakur; Aviral Kumar; Ajaikumar B Kunnumakkara
Journal:  Explor Target Antitumor Ther       Date:  2021-08-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.